1. Home
  2. KMDA vs ALTI Comparison

KMDA vs ALTI Comparison

Compare KMDA & ALTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KMDA
  • ALTI
  • Stock Information
  • Founded
  • KMDA 1990
  • ALTI 2020
  • Country
  • KMDA Israel
  • ALTI United States
  • Employees
  • KMDA N/A
  • ALTI N/A
  • Industry
  • KMDA Biotechnology: Pharmaceutical Preparations
  • ALTI Investment Managers
  • Sector
  • KMDA Health Care
  • ALTI Finance
  • Exchange
  • KMDA Nasdaq
  • ALTI Nasdaq
  • Market Cap
  • KMDA 398.5M
  • ALTI 388.9M
  • IPO Year
  • KMDA N/A
  • ALTI N/A
  • Fundamental
  • Price
  • KMDA $6.95
  • ALTI $3.97
  • Analyst Decision
  • KMDA Strong Buy
  • ALTI
  • Analyst Count
  • KMDA 2
  • ALTI 0
  • Target Price
  • KMDA $13.00
  • ALTI N/A
  • AVG Volume (30 Days)
  • KMDA 77.7K
  • ALTI 100.4K
  • Earning Date
  • KMDA 11-12-2025
  • ALTI 11-10-2025
  • Dividend Yield
  • KMDA 2.88%
  • ALTI N/A
  • EPS Growth
  • KMDA 27.97
  • ALTI N/A
  • EPS
  • KMDA 0.32
  • ALTI N/A
  • Revenue
  • KMDA $169,517,000.00
  • ALTI $217,760,000.00
  • Revenue This Year
  • KMDA $14.49
  • ALTI $19.78
  • Revenue Next Year
  • KMDA $10.12
  • ALTI $7.00
  • P/E Ratio
  • KMDA $21.01
  • ALTI N/A
  • Revenue Growth
  • KMDA 9.67
  • ALTI N/A
  • 52 Week Low
  • KMDA $5.43
  • ALTI $2.33
  • 52 Week High
  • KMDA $9.16
  • ALTI $5.00
  • Technical
  • Relative Strength Index (RSI)
  • KMDA 52.44
  • ALTI 58.81
  • Support Level
  • KMDA $6.72
  • ALTI $3.74
  • Resistance Level
  • KMDA $7.11
  • ALTI $3.90
  • Average True Range (ATR)
  • KMDA 0.19
  • ALTI 0.14
  • MACD
  • KMDA 0.03
  • ALTI 0.04
  • Stochastic Oscillator
  • KMDA 60.68
  • ALTI 91.94

About KMDA Kamada Ltd.

Kamada Ltd is a drug-focused, plasma-derived protein therapeutics company. It is involved in the business of developing, producing, and marketing specialty therapeutics using protein purification proprietary technology. Its product portfolio consists of Glassia, Bramitob, Foster, Ixiaro, Factor-IX, and others. The company has two segments namely, the Proprietary Products segment and the Distribution segment. It derives the majority of its revenue from the Proprietary products segment. The firm categorizes its products in Lung Disease, Vaccines, Haemophilia, Immunoglobulins, Critical care, and Diagnostics.

About ALTI AlTi Global Inc.

AlTi Global Inc is an independent wealth and asset manager providing entrepreneurs, multi-generational families, institutions, and emerging next-generation leaders with fiduciary capabilities as well as alternative investment strategies and advisory services. The firm has business which is organized into two business segments namely: Wealth & Capital Solutions and International Real Estate segment includes providing holistic solutions for wealth management clients through comprehensive range of wealth management services, including investment management and advisory services. International Real Estate segment includes assist investors with real estate co-investments, structuring and selecting partners with a proven track record with risk adjusted return characteristics.

Share on Social Networks: